[Effects of hyperbaric oxygenation on tumor growth]

Area of Science:

• Oncology
• Hyperbaric Medicine
• Experimental Pathology

Background:

• Hyperbaric oxygen therapy (HBOT) is explored for various medical applications.
• Its effects on tumor growth and metastasis are not fully understood.
• Previous research has yielded conflicting results regarding HBOT and cancer progression.

Purpose of the Study:

• To investigate the impact of hyperbaric oxygen on the growth and metastatic potential of specific tumor models.
• To determine if HBOT influences the development of chemically induced tumors.
• To assess the efficacy of HBOT as an adjunct in cancer treatment.

Main Methods:

• Utilized sarcoma 37 and melanoma B16 tumor models in mice (SHR and C57/Bl strains).
• Administered hyperbaric oxygen therapy to animals with tumors.
• Assessed tumor growth, metastatic spreading, and development of methylcholanthrene-induced tumors in rats.

Main Results:

• Hyperbaric oxygen did not demonstrate a stimulating effect on tumor growth or metastasis for sarcoma 37 and melanoma B16.
• No significant increase in tumor spread was observed with HBOT in transplanted or induced tumor models.
• An insignificant inhibitory effect of HBOT on tumor growth and development was noted in experimental animals.

Conclusions:

• Hyperbaric oxygen therapy does not promote the growth or spread of the studied transplantable and inducible tumors.
• The findings suggest HBOT is unlikely to exacerbate cancer progression in these experimental models.
• Further research is warranted to explore any potential subtle inhibitory effects or specific contexts where HBOT might be relevant in oncology.